Unicycive Therapeutics, Inc. (UNCY)
5.295
+0.10
(+2.02%)
USD |
NASDAQ |
Sep 03, 16:00
5.295
0.00 (0.00%)
After-Hours: 20:00
Unicycive Therapeutics Cash from Investing (Quarterly) : -0.023M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.023M |
| March 31, 2026 | -5.155M |
| December 31, 2025 | -12.07M |
| September 30, 2025 | -0.002M |
| June 30, 2025 | -0.006M |
| March 31, 2025 | -0.016M |
| December 31, 2024 | -0.022M |
| September 30, 2024 | -0.024M |
| June 30, 2024 | -0.02M |
| March 31, 2024 | -0.006M |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | -0.012M |
| March 31, 2023 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | -0.002M |
| December 31, 2021 | -0.029M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 0.00 |
| Theriva Biologics, Inc. | -0.003M |
| AbbVie, Inc. | -1.197B |
| Decoy Therapeutics, Inc. | -0.0424M |
| Nkarta, Inc. | 21.15M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -7.604M |
| Cash from Financing (Quarterly) | 14.44M |
| Free Cash Flow | -27.85M |
| Free Cash Flow Per Share (Quarterly) | -0.2825 |
| Free Cash Flow to Equity (Quarterly) | -7.40M |
| Free Cash Flow to Firm (Quarterly) | -7.603M |
| Free Cash Flow Yield | -23.12% |